Technical and clinical validation of a new immunoradiometric assay for human osteocalcin

European Journal of Endocrinology

Volumn 135, Issue 2, 1996, Pages 231-237

  Dumon, J C ^a   Wantier, H ^b   Mathieu, F ^b   Mantia, M ^a   Body, J J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b Medgenix   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PARATHYROID DISEASE; PRIORITY JOURNAL;

EID: 0029815648     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1350231     Document Type: Article

References (36)

1. Hauschka PV, Lian JB, Gallop PM. Direct identification of the calcium-binding amino-acid-α-carboxyglutamate in mineralized tissue. Proc Natl Acad Sci USA 1975;72:3925-9
2. Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K dependent bone protein found in plasma and its clearance by kidney and bone, J Biol Chem 1981;256:12760-6
3. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone gla-protein: a specific marker of bone formation in postmenopausal osteoporosis. Lancet 1984;1:1091-2
4. Lukert BP, Higgins JC, Stoskopf MM. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 1986;62:1056-8
5. Dumon JC, Body JJ. Circulating osteocalcin in hypercalcemic cancer patients: a comparative evaluation of two immunoassays. Diagn Oncol 1995;4:170-3
6. Delmas PD, Malaval L, Arlot ME, Meunier PJ. Serum bone gla-protein compared to bone histomorphometry in endocrine diseases. Bone 1985;6:339-41
7. Charhon SA, Delmas PD, Malaval L, Chavassieux PM, Arlot M, Chapuy MC, et al. Serum Bone GLA-protein in renal osteodystrophy - comparison with bone histomorphometry. J Clin Endocrinol Metab 1986;63:892-7
8. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ. Changes in markers of bone formation and resorption in a bed rest model of wightlessness. J Bone Miner Res 1993;8:1433-8
9. Knapen M, Hamulyák K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (Bone Gla Protein) and urinary calcium excretion. Ann Intern Med 1989;111: 1001-5
10. Pietschmann P, Woloszczuk W, Panzer S, Kyrle P, Smolen J. Decreased serum osteocalcin levels in phenprocoumon-treated patients. J Clin Endocrinol Metab 1988;66:1071-4
11. Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas P. Impairment of gamma carboxylation of circulating osteocalcin (Bone Gla Protein) in elderly women. J Bone Miner Res 1991;6:1211-6
12. Price PA, Nishimoto SK. Radioimmunoassay for the vitamin K dependent protein and its discovery in plasma. Proc Natl Acad Sci USA 1980;77:2234-8
13. Blumsohn A, Hannon RA, Eastell R. Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays. Clin Chem 1995;41:318-20
14. Parviainen M, Kuronen I, Kokko H, Lakaniemi M, Savolainen K, Mononen I. Two-site enzyme immunoassay for measuring intact human osteocalcin in serum. J Bone Miner Res 1994;9:347-54
15. Garnero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunooradiometric assay. J Bone Miner Res 1992;7:1389-98
16. Rosenquist C, Qvist P, Bjarnason N, Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995;41:1439-45
17. Taylor HK, Linkhart SG, Mohan S, Baylink DG. Development of a new radio immunoassay for human osteocalcin: evidence for a mid molecule epitope. Metabolism 1988;9:872-7
18. Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-7
19. Abraham GE. In: Cameron EHD, Hillier SG, Griffiths K, editors. Characterization of anti-steroid antisera in steroid immuno-assay; Cardiff: Alpha Omega Publishing, 1975:67-9
20. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64
21. Diego EM, Guerrero R, de la Piedra C. Six osteocalcin assays compared. Clin Chem 1994;40:2071-7
22. Body JJ, Dumon JC, Seraj F, Cleeren A. Recovery of parathyroid hormone secretion during correction of tumor-associated hypercalcemia. J Clin Endocrinol Metab 1992;74:1355-88
23. Banfi G, Daverio R. In vitro stability of osteocalcin.Clin Chem 1994;40:833-4
24. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994;40:358-63
25. Koyama N, Ohara K, Yokota H, Kurome T, Katayama M, Hino F, et al. A one step sandwich enzyme immunoassay of γ-carboxylated osteocalcin using monoclonal antibodies. J Immunol Methods 1991;139:17-23
26. Gundberg CM, Hauschka PV, Lian JB, Gallop PM. Ostocalcin: Isolation, characterization, and detection. Methods Enzymol 1984;107:516-44
27. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (Osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5-11
28. Durham BH, Robinson J, Fraser WD. Differences in the stability of intact osteocalcin in serum, lithium heparin plasma and EDTA plasma. Ann Clin Biochem 1995;32:422-423
29. Power MJ, O'Dwyer B, Breen E, Fottrell PF. Osteocalcin concentrations in plasma prepared with different anticoagulants. Clin Chem 1991;37:281-4
30. Tracy RP, Andrianorivo A, Riggs BL, Mann KG. Comparison of monoclonal and polyclonal antibody-based immunoassays for osteocalcin: A study of source of variation in assay results. J Bone Miner Res 1990;5:451-61
31. Poser JW, Esch FS, Ling HC, Price PA. Isolation and sequence of the vitamin K-dependent protein from human bone. Under-carboxylation of the first glutamic acid residue. J Biol Chem 1980;255:8685-91
32. 3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism. J Clin Invest 1988;82:861-5
33. Body JJ, Cleeren A, Pot M, Borkowski A. Serum osteocalcin (BGP) in tumor-induced hypercalcemia. J Bone Miner Res 1986;6:523-7
34. Stewart AF, Vignery A, Silverglate A, Ravin ND. LiVolsi V, Broadus AE, et al. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab 1982;55:219-27
35. Body JJ. Metastatic bone disease: clinical and therapeutic aspects. Bone 1992;13:S57-62
36. Fleisch H. Prospective use of bisphosphonates in osteoporosis. J Clin Endocrinol metab 1993;76:1397-8